ORCID iD (anklickbar): https://orcid.org/0000-0002-0243-8458
Auszug wichtiger Publikationen:
Maxim Kuzin, Ekkehard Haen, Christoph Hiemke, Benjamin Bochon, Karolina Bochon, Gerhard Gründer, Michael Paulzen, Georgios Schoretsanitis (2021): Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis. J Psychopharmacol. Mar;35(3):273-278. doi:10.1177/0269881120985166.
Georgios Schoretsanitis, Pierre Baumann, Andreas Conca, Otto Dietmaier, Giancarlo Giupponi, Gerhard Gründer, Martina Hahn, Xenia Hart, Ursula Havemann-Reinecke, Gudrun Hefner, Maxim Kuzin, Rainald Mössner, Daria Piacentino, Werner Steimer, Gerald Zernig, Christoph Hiemke (2020): Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs. Ther Drug Monit. doi: 10.1097/FTD.0000000000000830.
Kuzin, M., Scharrer, I., Nolan, D., Baumgartner, M., Paulzen, M., Schoretsanitis, G., & Xepapadakos, F. (2020): The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine‐a case report. Basic & Clinical Pharmacology & Toxicology. doi:10.1111/bcpt.13428.
Kuzin, M., Schoretsanitis, G., Haen, E., Dammann, G., Hiemke, C., Gründer, G., Paulzen, M. (2019): The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism, Pharmacopsychiatry, 2019-10-15, journal-article.
Kuzin, M., Schoretsanitis, G., Haen, E., Stegmann, B., Hiemke, C., Gründer, G., Paulzen, M. (2018): Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine, Clinical Pharmacokinetics, 2018-06, journal-article.
Paulzen M, Goecke TW, Kuzin M, Augustin M, Gründer G, Schoretsanitis G. (2018): Pregnancy exposure to quetiapin – Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and abstetrical outcomes. Schizophr Res. 2018 May;195:252-257. doi: 10.1016/j.schres.2017.09.043.
